General
US Food and Drug Association to approve Moderna’s COVID-19 vaccine on emergency basis
The US Food and Drug Administration (FDA) is working to approve Moderna’s coronavirus vaccine, its commissioner says.
Key points:
- An advisory panel overwhelmingly endorsed emergency use of the vaccine
- US Congress will get vaccinated with the first tranche of vaccine doses
- An emergency meeting will follow authorisation to recommend public use
The FDA informed Moderna that it will rapidly work towards the finalisation and issuance of emergency use authorisation (EUA) for its COVID-19 vaccine candidate, chief commissioner Stephen Hahn said late on Thursday local time.
The EUA is expected as early as late Thursday or Friday, providing another ray of hope to the United States, which has lost more than 300,000 lives to COVID-19. A record number of…
Continue Reading